The Holland Hybrid Heart project is developing a next-generation total artificial heart made from soft, biocompatible materials. This innovative device is designed to improve the lives of patients with severe heart failure who cannot receive a donor heart. Unlike current mechanical devices, which come with major risks and lifestyle limitations, the Holland Hybrid Heart aims to function fully inside the body without external power sources—offering a true alternative to heart transplantation.
With support from the TTT MedTech voucher, we are now taking the next steps towards real-world application. Over the next six months, our team will explore the legal and ethical frameworks for conducting first-in-human studies, identify key technology development needs, and seek validation from experts in the field. These insights will help shape a strategic business case and guide future development and funding.
This project brings together top researchers from Erasmus MC, AMOLF, TU Delft, University of Twente, Eindhoven University of Technology, and Saxion, working together to offer new hope to heart failure patients worldwide.